Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 19 studies | 63% ± 22% | |
| lung | 16 studies | 35% ± 13% | |
| peripheral blood | 15 studies | 33% ± 12% | |
| eye | 11 studies | 54% ± 22% | |
| intestine | 9 studies | 25% ± 9% | |
| kidney | 7 studies | 35% ± 17% | |
| liver | 6 studies | 42% ± 17% | |
| heart | 5 studies | 50% ± 12% | |
| bone marrow | 4 studies | 28% ± 11% | |
| uterus | 4 studies | 31% ± 12% | |
| skin | 4 studies | 25% ± 13% | |
| adipose | 4 studies | 48% ± 18% | |
| pancreas | 3 studies | 43% ± 20% | |
| breast | 3 studies | 29% ± 6% | |
| lymph node | 3 studies | 29% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 3011.65 | 1445 / 1445 | 100% | 14.38 | 183 / 183 |
| prostate | 100% | 3104.68 | 245 / 245 | 100% | 8.88 | 500 / 502 |
| ovary | 100% | 3112.84 | 180 / 180 | 100% | 8.35 | 428 / 430 |
| thymus | 100% | 3611.01 | 653 / 653 | 99% | 8.36 | 596 / 605 |
| breast | 100% | 3038.27 | 459 / 459 | 98% | 8.09 | 1100 / 1118 |
| brain | 100% | 3060.53 | 2634 / 2642 | 99% | 10.38 | 695 / 705 |
| lung | 100% | 3470.74 | 578 / 578 | 98% | 9.07 | 1132 / 1155 |
| skin | 100% | 3453.36 | 1809 / 1809 | 97% | 8.86 | 460 / 472 |
| stomach | 100% | 2332.28 | 359 / 359 | 97% | 9.55 | 278 / 286 |
| kidney | 100% | 2212.62 | 89 / 89 | 97% | 7.31 | 871 / 901 |
| intestine | 100% | 3523.98 | 966 / 966 | 97% | 6.55 | 509 / 527 |
| pancreas | 99% | 1708.37 | 326 / 328 | 97% | 6.39 | 173 / 178 |
| uterus | 100% | 3574.05 | 170 / 170 | 95% | 5.86 | 436 / 459 |
| bladder | 100% | 2847.71 | 21 / 21 | 94% | 5.63 | 473 / 504 |
| adrenal gland | 100% | 2795.92 | 258 / 258 | 90% | 4.77 | 208 / 230 |
| liver | 100% | 1912.83 | 226 / 226 | 80% | 3.59 | 324 / 406 |
| adipose | 100% | 2888.93 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 5.93 | 29 / 29 |
| spleen | 100% | 4243.49 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 2.09 | 1 / 1 |
| muscle | 100% | 2664.24 | 802 / 803 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 2750.68 | 1332 / 1335 | 0% | 0 | 0 / 0 |
| heart | 98% | 2346.84 | 848 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 98% | 2839.94 | 912 / 929 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 98% | 8.30 | 44 / 45 |
| eye | 0% | 0 | 0 / 0 | 89% | 4.65 | 71 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0035195 | Biological process | miRNA-mediated post-transcriptional gene silencing |
| GO_1900153 | Biological process | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay |
| GO_0031047 | Biological process | regulatory ncRNA-mediated gene silencing |
| GO_0035278 | Biological process | miRNA-mediated gene silencing by inhibition of translation |
| GO_0060213 | Biological process | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening |
| GO_0000932 | Cellular component | P-body |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005829 | Cellular component | cytosol |
| GO_0005515 | Molecular function | protein binding |
| GO_0003723 | Molecular function | RNA binding |
| Gene name | TNRC6B |
| Protein name | Trinucleotide repeat-containing gene 6B protein Alternative protein TNRC6B Trinucleotide repeat containing adaptor 6B |
| Synonyms | KIAA1093 |
| Description | FUNCTION: Plays a role in RNA-mediated gene silencing by both micro-RNAs (miRNAs) and short interfering RNAs (siRNAs) . Required for miRNA-dependent translational repression and siRNA-dependent endonucleolytic cleavage of complementary mRNAs by argonaute family proteins . As scaffolding protein associates with argonaute proteins bound to partially complementary mRNAs and simultaneously can recruit CCR4-NOT and PAN deadenylase complexes . . |
| Accessions | ENST00000446273.1 ENST00000301923.13 [Q9UPQ9-2] B0QYM5 ENST00000335727.13 [Q9UPQ9-1] ENST00000402203.5 [Q9UPQ9-2] Q9UPQ9 L8E721 ENST00000454349.7 [Q9UPQ9-3] H0Y720 ENST00000441751.5 |